Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Enzalutamide|DRUG: Placebo|DRUG: Paclitaxel
Sponsor: Pfizer
Collaborators: Astellas Pharma Inc|Medivation, Inc.